{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:10:15Z","timestamp":1773205815580,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jaip.2023.10.039","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T22:31:06Z","timestamp":1698445866000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Art of Immunotherapy"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5545-3945","authenticated-orcid":false,"given":"Harold S.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.10.039_bib1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2013.01.049","article-title":"Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology\/European Academy of Allergy and Clinical Immunology\/PRACTALL consensus report","volume":"131","author":"Burks","year":"2013","journal-title":"J\u00a0allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib2","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jaci.2012.12.1561","article-title":"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma","volume":"131","author":"Beeh","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jaip.2020.08.025","article-title":"Polyvalent mechanical bacterial lysate administration improves the clinical course of grass pollen-induced allergic rhinitis in children: a randomized controlled trial","volume":"9","author":"Janeczek","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.10.039_bib4","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/all.13201","article-title":"Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib5","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergy immunotherapy for allergic asthma: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib6","first-page":"CD008838","article-title":"Venom immunotherapy or preventing allergic reactions to insect stings","volume":"10","author":"Boyle","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2023.10.039_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2022.09.020","article-title":"Allergen immunotherapy for atopic dermatitis: systematic review and meta-analysis of benefits and harms","volume":"151","author":"Yepes-Nu\u00f1ez","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/cea.14005","article-title":"Is sublingual immunotherapy for asthma effective and safe?","volume":"51","author":"Fulmali","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 Focused updates to the Asthma Management Guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.rmed.2014.07.017","article-title":"SQ HDM SLIT-tablet (ALK) in treatment of asthma\u2014post hoc results from a randomized trial","volume":"108","author":"DeBlay","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.10.039_bib11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2023.10.039_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.13749","article-title":"EAACI guidelines on allergen immunotherapy: house dust mite-driven allergic asthma","volume":"74","author":"Agache","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/all.13077","article-title":"Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaci.2008.10.028","article-title":"Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy","volume":"123","author":"Ru\u00ebff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/all.13319","article-title":"EAACI guidelines on allergen immunotherapy: IgE-mediated food allergy","volume":"73","author":"Pajno","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.10.039_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ-grass sublingual immunotherapy tablet asthma prevention (G) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EDAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2023.10.039_bib19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter. Third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib20","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jaip.2022.03.005","article-title":"Exposure to allergen-specific immunotherapy in pregnancy and risk of congenital malformations and other adverse pregnancy outcomes","volume":"10","author":"Mitselou","year":"2022","journal-title":"J\u00a0Allergy CIin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.10.039_bib21","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/all.14785","article-title":"B-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy","volume":"76","author":"Sturm","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib24","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s12328-021-01520-5","article-title":"A\u00a0case series of sublingual immunotherapy-induced eosinophilic esophagitis: stop or spit","volume":"13","author":"Fujiwara","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.10.039_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s40521-023-00338-5","article-title":"Allergen immunotherapy: state of the art","volume":"10","author":"Nelson","year":"2023","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.2016.21040","article-title":"Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis. The GRASS randomized clinic trial","volume":"317","author":"Scadding","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2023.10.039_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/cea.12241","article-title":"Immunological comparison of allergen immunotherapy against grass allergy","volume":"44","author":"Aasbjerg","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib28","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jaip.2019.01.058","article-title":"AAAAI\/ACAAI Subcutaneous Immunotherapy Surveillance Study 2013-2017: fatalities, infections, delayed reactions, and use of epinephrine autoinjectors","volume":"7","author":"Epstein","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.10.039_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anai.2021.03.011","article-title":"Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): post-injection monitoring and severe asthma","volume":"127","author":"Epstein","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaip.2016.08.017","article-title":"Epinephrine use in clinical trials of sublingual immunotherapy tablets","volume":"5","author":"Nolte","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.10.039_bib31","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/17512433.2016.1237874","article-title":"Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient","volume":"11","author":"Nelson","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jaip.2023.10.039_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13223-015-0109-6","article-title":"Management of the polyallergic patient with allergy immunotherapy: a practice-based approach","volume":"12","author":"Demoly","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM196509232731302","article-title":"A\u00a0double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever","volume":"273","author":"Lowell","year":"1965","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.10.039_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jama.1967.03130120023006","article-title":"Comparison of two dosages of ragweed extract in the treatment of pollinosis","volume":"201","author":"Franklin","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2023.10.039_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1081-1206(10)60718-1","article-title":"Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients","volume":"98","author":"Marogna","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2009.04.037","article-title":"Response to sublingual immunotherapy with grass pollen extracts: monotherapy versus combination in a multiallergen extract","volume":"124","author":"Amar","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","article-title":"Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy","volume":"132","author":"Kiel","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2010.06.045","article-title":"How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers\u2019 viewpoint","volume":"126","author":"Senna","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib39","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass allergen tablets; a randomized, controlled trial in seasonal rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib40","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib41","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2013.03.019","article-title":"Randomized, controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults","volume":"131","author":"Creticos","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib42","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jaci.2014.12.1911","article-title":"Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber","volume":"135","author":"Nolte","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jaci.2009.12.931","article-title":"Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen","volume":"125","author":"Skoner","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaci.2013.10.041","article-title":"Randomized, double-blind, placebo-controlled immunotherapy for allergic rhinoconjunctivitis trial of standardized ragweed sublingual-liquid for allergic rhinoconjunctivitis","volume":"133","author":"Creticos","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib45","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaci.2010.11.045","article-title":"House dust mite sublingual immunotherapy: results of a U.S. trial","volume":"127","author":"Bush","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.anai.2019.03.023","article-title":"Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey","volume":"122","author":"Sivam","year":"2019","journal-title":"Ann allergy asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.anai.2012.03.009","article-title":"Survey on immunotherapy practice patterns: dose, dose adjustments, and duration","volume":"108","author":"Larenas-Linnemann","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib48","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2500\/aap.2021.42.210061","article-title":"How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?","volume":"42","author":"Nelson","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2023.10.039_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.anai.2012.04.012","article-title":"Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts","volume":"108","author":"Grier","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2003.11.024","article-title":"Manufacturing and standardizing fungal allergen products","volume":"113","author":"Esch","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaci.2004.08.049","article-title":"Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract","volume":"114","author":"Nanda","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib52","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib53","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaci.2010.11.036","article-title":"Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children","volume":"127","author":"Kuna","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib54","first-page":"430","article-title":"Immunotherapy with a standardized Dermatophagoides pteronyssinus extract V. Duration of the efficacy of immunotherapy after its cessation","volume":"51","author":"Des Roches","year":"1996","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1398-9995.1994.tb00771.x","article-title":"Booster immunotherapy (BIT)","volume":"49","author":"Ebner","year":"1994","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib56","first-page":"5","article-title":"Prolonged efficacy of the 300 IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score","volume":"22","author":"Didier","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaci.2010.10.025","article-title":"Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy","volume":"127","author":"Tabar","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2012.07.015","article-title":"Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy","volume":"109","author":"Stelmach","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaci.2010.08.030","article-title":"Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study","volume":"126","author":"Marogna","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib60","series-title":"Textbook of allergy for the clinician","first-page":"165","article-title":"Allergen immunotherapy","author":"Nelson","year":"2021"},{"key":"10.1016\/j.jaip.2023.10.039_bib61","first-page":"409","article-title":"Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts","volume":"73","author":"Portnoy","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2013.01.015","article-title":"AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, year 3: what practices modify the risk of systemic reactions","volume":"110","author":"Epstein","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib63","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.anai.2016.09.005","article-title":"Comparison of systemic reactions in rush, cluster and standardized build aeroallergen immunotherapy","volume":"117","author":"Winslow","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib64","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mai.2000.110468","article-title":"Local reactions during allergen immunotherapy do not require dose adjustment","volume":"106","author":"Tankersley","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1081-1206(10)61551-7","article-title":"The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction","volume":"92","author":"Kelso","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaci.2009.07.048","article-title":"The LOCAL study: local reactions do not predict local reaction in allergen immunotherapy","volume":"124","author":"Calabria","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib67","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1081-1206(10)60626-6","article-title":"Increased frequency of large local reactions among systemic reactors during subcutaneous allergy immunotherapy","volume":"99","author":"Roy","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.anai.2018.04.007","article-title":"SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration","volume":"121","author":"Bernstein","year":"2018","journal-title":"Ann allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0091-6749(93)90030-J","article-title":"Survey of fatalities from skin testing and immunotherapy 1985-1989","volume":"92","author":"Reid","year":"1993","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib70","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001","volume":"113","author":"Bernstein","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib71","first-page":"163","article-title":"Antihistamine premedication improves safety and efficacy of allergy immunotherapy","volume":"129","author":"Wang","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib72","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jaip.2019.11.030","article-title":"Epinephrine-coated syringe for SCIT reduced local reactions: a randomized, double-blind placebo-controlled trial","volume":"8","author":"Sapsaprang","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.10.039_bib73","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2500\/aap.2020.41.190018","article-title":"Efficacy of epinephrine and diphenhydramine rinses in decreasing local reactions to subcutaneous aeroallergen immunotherapy","volume":"41","author":"Mustafa","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2023.10.039_bib74","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.anai.2018.09.048","article-title":"Adverse event profile of SQ house dust mite sublingual immunotherapy tablet after treatment interruptions","volume":"121","author":"Tilles","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.10.039_bib75","first-page":"557","article-title":"Nonfatal systemic allergic reactions induced by skin testing and immunotherapy","volume":"71","author":"Lin","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2023.10.039_bib76","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jaip.2017.03.021","article-title":"Systemic reactions to immunotherapy during mountain cedar season: implications for seasonal dose adjustment","volume":"5","author":"Wong","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.10.039_bib77","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jaip.2017.11.040","article-title":"Systemic reactions in pediatric patients receiving standardized allergen subcutaneous immunotherapy with and without seasonal dose adjustment","volume":"6","author":"Albuhairi","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.10.039_bib78","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/03007995.2018.1552044","article-title":"Ways to increase adherence to allergen immunotherapy","volume":"35","author":"Pitsios","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaip.2023.10.039_bib79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1398-9995.2009.02223.x","article-title":"Sublingual immunotherapy: adherence based on timing and monitoring control visits","volume":"65","author":"Vita","year":"2010","journal-title":"Allergy"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823011935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823011935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:39:38Z","timestamp":1761975578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823011935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213219823011935"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.10.039","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Art of Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}